Compare BVS & BETR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BVS | BETR |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.1M | 538.7M |
| IPO Year | 2016 | N/A |
| Metric | BVS | BETR |
|---|---|---|
| Price | $10.49 | $38.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $14.00 | ★ $40.00 |
| AVG Volume (30 Days) | 416.1K | ★ 517.9K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.52 | $54.06 |
| Revenue Next Year | $7.06 | $66.68 |
| P/E Ratio | $29.97 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.81 | $10.81 |
| 52 Week High | $9.98 | $94.06 |
| Indicator | BVS | BETR |
|---|---|---|
| Relative Strength Index (RSI) | 74.46 | 55.60 |
| Support Level | $8.43 | $26.89 |
| Resistance Level | N/A | $41.23 |
| Average True Range (ATR) | 0.36 | 3.54 |
| MACD | 0.11 | 0.09 |
| Stochastic Oscillator | 97.35 | 49.90 |
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.